News
Elanco Animal Health Inc.’s stock was headed for an 18-month high on Monday after the company said it has agreed to sell its aqua business to Merck Animal Health for $1.3 billion in cash, in a ...
Elanco has transformed into a diversified animal health company which operates 200 brands and expects 3-4% growth per annum. Six blockbusters launch by 2025 to catalyze growth, with 2 pending ...
Hosted on MSN21d
Elanco (NYSE:ELAN) Beats Q1 Sales Targets, Full-Year Outlook Slightly Exceeds ExpectationsAnimal health company Elanco (NYSE:ELAN) reported Q1 CY2025 results , but sales were flat year on year at $1.19 billion. The company’s full-year revenue guidance of $4.55 billion at the midpoint ...
Animal health company Elanco (NYSE:ELAN) will be announcing earnings results tomorrow before market open. Here’s what to look for. Elanco missed analysts’ revenue expectations by 0.6% last ...
After an acquisition of Bayer Animal Health in 2020, Elanco has made progress in paying down debt. Robust pipeline with six potential blockbuster products to be launched in 2024 and 2025.
Elanco's share price has come under pressure amid new concerns over a key product. Seresto is a tick and flea collar designed to work on both cats and dogs. Unfortunately, the collar has built up ...
BofA analyst Michael Ryskin lowered the firm’s price target on Elanco (ELAN) to $13 from $16 and keeps a Buy rating on the shares.Heading into Q1 earnings, the firm says sentiment on its animal ...
Elanco Animal Health Inc. said Monday it plans to restructure operations, which will result in the loss of 420 jobs. The Greenfield-based maker of vaccines, antibiotics and other animal-health ...
Elanco Animal Health and Purdue University are partnering to create a three-acre research facility near the former site of the GM stamping plant in Indianapolis. The facility will be part of a new ...
Elanco ELAN-0.08%decrease; red down pointing triangle Animal Health has agreed to a $15 million settlement with the Securities and Exchange Commission over claims that it had misled investors ...
Aug 1 (Reuters) - Animal health giant Elanco (ELAN.N), opens new tab is facing a new lawsuit accusing it of monopolizing the market for some flea and tick treatments, causing pet owners to pay ...
Federal regulators have approved a new dermatology treatment for itchy dogs made by Elanco Animal Health Inc. that the company has touted as a potential blockbuster. Greenfield-based Elanco said ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results